Summary of Serologic Data, Nested RT-PCR Analysis, and Antigen Determination in PBLs From IM Patients
| Patient No./Age (yr)/Sex . | Duration . | Serologic Data . | Nested PCR . | |||||
|---|---|---|---|---|---|---|---|---|
| . | . | EA IgG . | VCA IgM . | VCA IgG . | EBNA IgG . | BZLF1 (Zta) . | BALF2 (EA) . | BcLF1 (VCA) . |
| IM7/19/M | 21 | 1:160 | 1:20 | 1:640 | <1:10 | + | + | − |
| IM8/14/F | 21 | 1:80 | 1:640 | 1:1,280 | <1:10 | − | − | − |
| IM9/14/F | 14 | 1:320 | 1:640 | 1:1,280 | <1:10 | + | − | − |
| IM10/15/F | 12 | 1:160 | 1:640 | 1:1,280 | <1:10 | + | + | − |
| IM11/16/M | 11 | 1:10 | 1:320 | 1:1,280 | <1:10 | + | − | − |
| IM12/17/M | 12 | 1:640 | 1:640 | 1:1,280 | <1:10 | + | − | − |
| IM13/15/F | 7 | 1:80 | 1:320 | 1:640 | <1:10 | + | + | − |
| IM14/23/M | 6 | 1:80 | 1:320 | 1:640 | <1:10 | + | − | + |
| IM16/16/M | 14 | 1:160 | 1:80 | 1:640 | <1:10 | + | + | + |
| IM17/25/F | 28 | 1:160 | 1:20 | 1:640 | <1:10 | + | − | − |
| IM18/22/F | 3 | 1:10 | 1:20 | 1:640 | <1:10 | − | + | − |
| IM19/18/M | 14 | 1:1,280 | 1:640 | 1:2,560 | <1:10 | + | − | − |
| IM20/23/M | 10 | 1:160 | 1:640 | 1:2,560 | <1:10 | + | − | + |
| IM21/20/M | 16 | 1:640 | 1:320 | 1:1,280 | <1:10 | + | + | + |
| IM22/28/M | 9 | 1:160 | 1:1,280 | 1:320 | <1:10 | + | + | − |
| IM24/26/F | 14 | 1:64 | 1:32 | 1:1,024 | <1:10 | + | + | − |
| Patient No./Age (yr)/Sex . | Duration . | Serologic Data . | Nested PCR . | |||||
|---|---|---|---|---|---|---|---|---|
| . | . | EA IgG . | VCA IgM . | VCA IgG . | EBNA IgG . | BZLF1 (Zta) . | BALF2 (EA) . | BcLF1 (VCA) . |
| IM7/19/M | 21 | 1:160 | 1:20 | 1:640 | <1:10 | + | + | − |
| IM8/14/F | 21 | 1:80 | 1:640 | 1:1,280 | <1:10 | − | − | − |
| IM9/14/F | 14 | 1:320 | 1:640 | 1:1,280 | <1:10 | + | − | − |
| IM10/15/F | 12 | 1:160 | 1:640 | 1:1,280 | <1:10 | + | + | − |
| IM11/16/M | 11 | 1:10 | 1:320 | 1:1,280 | <1:10 | + | − | − |
| IM12/17/M | 12 | 1:640 | 1:640 | 1:1,280 | <1:10 | + | − | − |
| IM13/15/F | 7 | 1:80 | 1:320 | 1:640 | <1:10 | + | + | − |
| IM14/23/M | 6 | 1:80 | 1:320 | 1:640 | <1:10 | + | − | + |
| IM16/16/M | 14 | 1:160 | 1:80 | 1:640 | <1:10 | + | + | + |
| IM17/25/F | 28 | 1:160 | 1:20 | 1:640 | <1:10 | + | − | − |
| IM18/22/F | 3 | 1:10 | 1:20 | 1:640 | <1:10 | − | + | − |
| IM19/18/M | 14 | 1:1,280 | 1:640 | 1:2,560 | <1:10 | + | − | − |
| IM20/23/M | 10 | 1:160 | 1:640 | 1:2,560 | <1:10 | + | − | + |
| IM21/20/M | 16 | 1:640 | 1:320 | 1:1,280 | <1:10 | + | + | + |
| IM22/28/M | 9 | 1:160 | 1:1,280 | 1:320 | <1:10 | + | + | − |
| IM24/26/F | 14 | 1:64 | 1:32 | 1:1,024 | <1:10 | + | + | − |
Abbreviations: F, female; M, male; +, detectable; −, not detectable.
Duration of clinical symptoms (mo).